Synaptic Mechanisms Underlying Rapid Antidepressant Action of Ketamine
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Recent clinical studies have demonstrated that a single subpsychotomimetic dose of ketamine, an ionotropic glutamatergic N-methyl-D-aspartate (NMDA) receptor antagonist, produces a rapid antidepressant response in patients with major depressive disorder, with effects lasting up to 2 weeks. Despite enthusiasm about this unexpected efficacy of ketamine, its widespread use as a fast-acting antidepressant in routine clinical settings is curtailed by its abuse potential as well as possible psychotomimetic effects. However, the ability of ketamine to produce a rapid and long-lasting antidepressant response in patients with depression provides a unique opportunity for investigation of mechanisms that mediate these clinically relevant behavioral effects. From a mechanistic perspective, it is easy to imagine how activation of NMDA receptors may trigger cellular and behavioral responses; it is relatively more difficult, however, to envision how transient blockade of one of the key pathways for neuronal communication produces a persistent beneficial effect. The authors discuss recent work linking ketamine's mechanism of action to homeostatic synaptic plasticity processes activated after suppression of NMDA-mediated glutamatergic neurotransmission. They focus on their recent work demonstrating that ketamine-mediated blockade of NMDA receptors at rest deactivates eukaryotic elongation factor 2 (eEF2) kinase, resulting in reduced eEF2 phosphorylation and desuppression of rapid dendritic pr…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Self-citationmTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists
Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881
Homeostatic plasticity in the developing nervous system
Turrigiano, G. G., & Nelson, S. B. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1327 · Cited by 2,485
NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses
Autry, A. E., Adachi, M., Nosyreva, E., Na, E. S., Los, M. F., Cheng, P.-F., Kavalali, E. T., & Monteggia, L. M. (2011) · Nature · doi:10.1038/nature10130 · Cited by 1,926
Self-citationMoghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission
Popoli, M., Yan, Z., McEwen, B. S., & Sanacora, G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3138 · Cited by 1,393
Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
Rossi, A., Kapahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., & Santoro, M. G. (2000) · Nature · doi:10.1038/47520 · Cited by 1,310
Research works printed but not linked: 2
- Schwartz PH, 1991, Res Commun Chem Pathol Pharmacol, 73, 181
- Gómez-Galán M, Mol Psychiatry
Cited by
Items 201–276 of 276
Medication for Depression: Monoamine Enhancers and Esketamine (Antidepressants)
Park, S., & Shen, W. W. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_133-1 · Cited by 5
Dopamine ADHD/OCD Theories: Is Glutamine Part of the Story?
(2015) · Neurotransmitter · doi:10.14800/nt.891 · Cited by 5
“While these effects have been postulated to be mediated at cortical vs subcortical receptors (Levy ([10]); Levy and Dadds ([24])) it is possible that functional selectivity at important receptor sites is also a factor.”
BackgroundInfluentialWerner, F.-M., & Coveñas, R. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190410165243 · Cited by 5
Lee, K., Kumar, E. A., Dalby, K. N., & Ghose, R. (2019) · Protein Science · doi:10.1002/pro.3753 · Cited by 5
O molekularnej patogenezie stresu i depresji
Pels, K. K. (2020) · Kosmos · doi:10.36921/kos.2020_2619 · Cited by 5
Costa, B. M., Hines, D., Phillip, N., Boehringer, S. C., Anandakrishnan, R., & Davis, J. L. (2025) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/j.jpet.2025.103401 · Cited by 4
Türe, A., Özdemir, B., Çeçe, O., Armağan, G., Erdoğan, M. A., Erdoğan, Ö., Çevik, Ö. D., & Küçükgüzel, İ. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.138428 · Cited by 4
Stakeholders’ Views on Barriers to Research on Controlled Substances
Rhodes, E., Andreae, M. H., Bourgiose, T., Indyk, D., Rhodes, R., & Sacks, H. S. (2016) · The Journal of Clinical Ethics · doi:10.1086/jce2016274308 · Cited by 4
Hilal, F. F., Jeanblanc, J., & Naassïla, M. (2023) · Biologie Aujourd hui · doi:10.1051/jbio/2023028 · Cited by 4
Is a Combination of Pharmacotherapy and Psychotherapy Superior to Each Alone?
Choi, K., & Kim, Y. (2017) · Springer eBooks · doi:10.1007/978-981-10-6577-4_21 · Cited by 4
Toward Better Animal Models for Molecular Psychiatry
Monteggia, L. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.10.019 · Cited by 4
“The basic research into the mechanisms of rapid antidepressant action has elucidated key points of convergence among diverse antidepressant treatments (15) without any clear indications that they are “fixing” the underlying basis of depression but nonetheless raising the hope for more reliable and effective approaches…”
Self-citationShen, Y. F. (2015) · TSpace (University of Toronto) · Cited by 3
Szybko działające antydepresanty — punkt zwrotny w leczeniu depresji?
Gabryel, B., Basiaga, B., Bednarz, K., & Żądecka-Kobiałka, K. (2023) · Psychiatria · doi:10.5603/psych.2022.0007 · Cited by 2
Huang, R.-H., Lin, B., Yu, L., Luo, Q., Tian, H., Li, C., Wei, N., Zhuang, S., Chen, J., & Li, Y. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1630158 · Cited by 2
“The underlying mechanism is that S-ketamine can serve as an NMDAR modulator and increase the BDNF concentration in the prefrontal cortex and hippocampus (Aleksandrova and Phillips, 2021; Zanos and Gould, 2018; Kavalali and Monteggia, 2012).”
Zimbelman, A. R., Wong, B., Murray, C. H., Wolf, M. E., & Stefanik, M. T. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04283-w · Cited by 2
“In the hippocampus, NMDAR-mediated miniature synaptic events resulting from spontaneous transmission exert a suppressive effect on protein translation and thus NMDAR antagonists such as APV lead to increased translation [79–82].”
Busz, A., Schmidt, E. (. J. )., van den Brink, R., Foeken, K., de Jong, M., Mertens, J. (. B. C. )., van Noorden, M. S., Olivier, E. (. J. F. L. )., Schruers, K. R. J., Schutters, S. I. J., et al. (2025) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2025.100905 · Cited by 2
Affect, Mood, Emotions: Depressive Disorders and Bipolar and Related Disorders
Leigh, H. (2014) · Springer eBooks · doi:10.1007/978-3-319-11005-9_15 · Cited by 2
Clinical Effects and Applications of Ketamine
Roback, M. G. (2017) · Springer eBooks · doi:10.1007/978-3-319-47609-4_14 · Cited by 2
Robson, M. J. (2013) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.3661 · Cited by 2
“…increase in brain-derived neurotrophic factor (BDNF), mediated through eukaryotic elongation factor 2 (eEF2) kinase signaling through a modulation of NMDA receptors at rest by ketamine as a mechanism behind the antidepressant actions of the drug (Autry et al., 2011; Kavalali and Monteggia, 2012).”
BackgroundÖzler, C., Özkan, E., Shomalizadeh, N., Kesibi, J., Sapancı, S., Akpunar, F., Uçar, E. A., & Özdemir, Y. (2025) · Experimental Brain Research · doi:10.1007/s00221-025-07085-w · Cited by 1
“One of the drawbacks of ketamine is that it creates several psychotomi-metic effects such as a dissociative state, hallucinations, and time distortion (Kavalali and Monteggia 2012; Zorumski et al. 2016 ).”
Carmellini, P., Cuomo, A., Rescalli, M. B., Pinzi, M., Dourmas, A., & Fagiolini, A. M. (2026) · Pharmaceuticals · doi:10.3390/ph19050662 · Cited by 1
“Patients with preserved connectivity and stress resilience may benefit from gradual monoaminergic modulation, while those with network rigidity or neurotrophic depletion may require interventions that reopen windows of plastic potential [72].”
Seo, Y. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27136084 · Cited by 1
“Synaptic and rapid-acting antidepressant models further support the view that ketamine reopens adaptive plasticity states [107,108].”
Uzay, B., Ma, Z., Uzay, İ. A., Alten, B., Monteggia, L. M., & Kavalali, E. T. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02535-7 · Cited by 1
Self-citationKetamine’s Mechanisms of Rapid Antidepressant Activity: Evidence from Preclinical Studies
Hermes, G., & Sanacora, G. (2016) · Springer eBooks · doi:10.1007/978-3-319-42925-0_6 · Cited by 1
The impact of antipsychotics on the trafficking of neurotransmitter receptors
Fernandes, A. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
The Interactive Effects of Ketamine and Magnesium Upon Depressive-like Pathology
Razmjou, S. (2014) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2014-10484 · Cited by 1
Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery
Tanaka, M. (2026) · Biomedicines · doi:10.3390/biomedicines14061265
Modulation of NMDA Receptor Activity During Physiological and Pathophysiological Events
Emnett, C. M. (2014) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7wm1bj6
“The temporal delay in anti-depressant effects relative to psychotomimetic effects suggests the involvement of persistent signaling pathways rather than just acute NMDAR block (Kavalali and Monteggia, 2012).”
BackgroundConsciousness = learning? The role of recurrent processing in perceptual learning
Meuwese, J. D. I. (2014) · UvA-DARE (University of Amsterdam)
Kennon‐McGill, S. (2014) · KU ScholarWorks (The University of Kansas)
Rapid Antidepressant Action of Ketamine in Psychiatric Patients with Suicidality - a Case Series
Raj, R., & Kumar, R. (2014) · American Journal of Medical Sciences and Medicine · doi:10.12691/ajmsm-2-2-4
Experimental Pharmacologic Approaches for the Reduction of Suicidal Ideation and Behavior
Ballard, E. D., Richards, E. M., Ionescu, D. F., Niciu, M. J., Voort, J. V., & Zarate, C. A. (2014) · Springer eBooks · doi:10.1007/978-3-319-09964-4_12
Basic Foundations of Diagnosis, Psychiatric Diagnosis, and Final Common Pathway Syndromes
Leigh, H. (2014) · Springer eBooks · doi:10.1007/978-3-319-11005-9_7
Study of nuclear receptor dynamics by BRET
Cotnoir‐White, D. (2014) · doi:10.71781/28997
Think ing Thr ough Consciousness
Hanson, E. (2013)
Epigenetik und Bildgebung treiben die Grundlagenforschung an: 3. Psychiatrie-Update
Häckel, A. (2013) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-013-0262-z
Pharmakologische Grundlagen: Mechanismen und Variabilität der Wirkung psychoaktiver Substanzen
Hohmann, N. (2017) · Springer eBooks · doi:10.1007/978-3-642-55125-3_93
Mechanisms of NMDA receptor inhibition by memantine and ketamine
Glasgow, N. G. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
Calcium regulation of inhibitory synaptic transmission
Willliams, C. (2016)
Chronotherapeutics in Bipolar and Major Depressive Disorders: Implications for Novel Therapeutics
Duncan, W. C. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_7
Regulation of elongation factor 2 kinase (eEF-2K) by phosphorylation
Tavares, C. D. J. (2014) · Texas ScholarWorks (Texas Digital Library) · doi:10.15781/t2gx4509n
Encéphalites à anticorps anti-NMDAR : étude clinique et mécanistique
Bost, C. (2017) · theses.fr (ABES) · doi:10.70675/6a4d9361zacabz4f75z9186z3142d27effde
The Opposing Roles of GluN2C and GluN2D NMDA Receptor Subunits in Modulating Neuronal Oscillations
Mao, Z. (2018) · DigitalCommons@UNMC
Aleksandrova, L. R. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0383291
“to synaptogenesis in the rodent HPC and mPFC, reversing the stress-induced synaptic destabilization and neuronal atrophy (Aleksandrova et al., 2017a; Autry et al., 2011; Fukumoto et al., 2015; Garcia et al., 2008; Kavalali and Monteggia, 2012; Li et al., 2011, 2010; Maeng et al., 2008; Marsden, 2013; Moda-Sava et al.,…”
BackgroundKetamine and Norketamine: Enantioseparation, Enantioselective Ecotoxicity and Biodegradation Studies
Pérez‐Pereira, A. (2019) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Psychiatric morbidity in general practice--its presentation, recognition and classification.
Kessel, N. (1973) · PubMed
HIV gp120-induced synaptic changes -- modulation by the endocannabinoid system and NMDARs
Zhang, X. (2019) · University of Minnesota Digital Conservancy (University of Minnesota)
Thinking Through Consciousness
Hanson, E. (2013) · doi:10.15760/honors.37
Kotkowska, Z., & Strzelecki, D. (2021) · Preprints.org · doi:10.20944/preprints202107.0507.v2
Kolb, B. E. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735536620.793560172
Pharmakologische Grundlagen: Mechanismen und Variabilität der Wirkung psychoaktiver Substanzen
Hohmann, N. (2016) · Springer eBooks · doi:10.1007/978-3-642-55214-4_93-1
Do Molecular Interventions (Ketamine) Re-establish Synapses in Affected Brain Structures?
Bennett, M. R. (2024) · Springer eBooks · doi:10.1007/978-981-97-2803-9_10
Medications for Depression: Monoamine Enhancers and Esketamine (Antidepressants)
Park, S., & Shen, W. W. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_133
Zhang, S., Wang, L., Yang, J., Feng, X., Yang, R., & Lei, X. (2024) · Thermal Science and Engineering Progress · doi:10.1016/j.tsep.2024.103145
RetractedKetamine in the Treatment of Depression
Kaczmarska, U., Cioch, M. J., Nowak, J., Woźniak, A., Hermanowicz, K., Najdek, A., Oleksy, D., Komada, D., Doman, K., & Mycyk, M. (2025) · Journal of Education Health and Sport · doi:10.12775/jehs.2025.78.57672
“The NMDA receptor has a characteristic role in later synaptic signalling and moderating quick antidepressant-like results that cannot be imitated by other means of altering postsynaptic glutamatergic responses [18].”
The Current Status of Antidepressant Drugs and the Exploration of New Targets
张, 陈. (2025) · Hans Journal of Medicinal Chemistry · doi:10.12677/hjmce.2025.132021
Li, M., Şen, Z. D., Danyeli, L. V., Javaheripour, N., & Walter, M. (2025) · Neuromethods · doi:10.1007/978-1-0716-4603-8_14
Es-Safi, S., Bourcier‐Lucas, C., Abrial, E., Cathala, A., Lesté-Lasserre, T., Deurwaerdère, P. D., Revest, J., Mazella, J., Haddjeri, N., & Lucas, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.24.684353
“The mechanisms involved seem to be complex, putting into play both a direct action on these cells, and an indirect one via the blockade of NMDA receptors in GABAergic cortical interneurons (35,59-60).”
Li, L. (2020) · eScholarship@McGill (McGill) · doi:10.82308/44525
Neuropsychological mechanisms of ketamine antidepressant effect
Costi, S. (2025) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-wvydgvb7o
Simard, S. F. (2025) · Carleton University's Institutional Repository (MacOdrum Library, Carleton University) · doi:10.22215/etd/2025-16757
Xia, J., Cui, L., Yuan, Q., An, X., Sun, X., & 徐虹羽 (2026) · Research Square · doi:10.21203/rs.3.rs-8341508/v1
Lees, T., Scott, J. N., Boyle, B. W., Esfand, S. M., Linton, S. R., Miller, C., Li, M., Woronko, S. E., Dunayev, R., Bogdanov, M., et al. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-03928-4
Martin, E. (2017) · theses.fr (ABES) · doi:10.70675/3f77e643zf119z465fzbc28z20877ecebf8e
Rôle des récepteurs 5-HT4 dans la modulation de la plasticité synaptique au sein du gyrus denté
Es-Safi, S. (2025) · theses.fr (ABES) · doi:10.70675/954404efzad5fz445dz86aez41d9d3dd8e65
Singhal, Y., Pavan Gaurav, R., Saji, S., Pingoliya, S. K., & Ghera, D. K. (2026) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2026.2679720
“Unlike traditional antidepressants that work on serotonin and dopamine pathways, ketamine acts through NMDA receptor antagonism, enhancing glutamate transmission and synaptic plasticity (32).”
Cheung, N. (2026) · Frontiers in Computational Neuroscience · doi:10.3389/fncom.2026.1799705
“The biological motivation was the literature linking NMDA-antagonist-related rapid antidepressant effects to synaptic plasticity, including mTOR-dependent synapse formation and downstream plasticity mechanisms (Li et al., 2010; Duman et al., 2012; Kavalali and Monteggia, 2012).”
New Developments in Anesthetic Mechanism Research
Deng, J., & Zuo, Z. (2026) · Springer eBooks · doi:10.1007/978-3-032-25214-2_2
Cheng, T. (n.d.) · PolyU Institutional Research Archive (Hong Kong Polytechnic University)
Blasi, C. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15207914
“…may be linked to homeostatic synaptic plasticity processes triggered by the suppression of NMDA receptor-mediated glutamatergic neurotransmission [48]. https://doi.org/10.3390/jcm15207914 Indeed, impaired neural plasticity and dysfunction of NMDARs caused by an altered glutamatergic signaling…”
InfluentialO impacto de antipsicóticos no tráfego de receptores de neurotransmissores
Fernandes, A. (2016) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Fijtman, A., Lally, N., Evans, J. W., Jones, G. H., Roiser, J. P., & Zarate, C. A. (2026) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2026.112367
Sala, N., Paoli, C., Bonifacino, T., Mingardi, J., Schiavon, E., Via, L. L., Milanese, M., Tornese, P., Datusalia, A. K., Rosa, J., et al. (2022) · doi:10.3389/fphar.2022.759626.s002
Metadata
- Authors
- Kavalali, E. T., & Monteggia, L. M.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Venue
- American Journal of Psychiatry
- Published
- 2012-11
- Volume
- 169
- Issue
- 11
- Pages
- 1150-1156
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2124203952
- Cited by
- 258
- References
- 48
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 10 · 2023: 11 · 2022: 16 · 2021: 18 · 2020: 11 · 2019: 19 · 2018: 15 · 2017: 17 · 2016: 20 · 2015: 27 · 2014: 31 · 2013: 31 · 2012: 2
- FWCI
- 3.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH 070727, R01MH066198, MH-066198, R01MH070727)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- ketamine, major depressive disorder, NMDA receptor antagonism, homeostatic plasticity, eEF2K, eEF2 phosphorylation, brain-derived neurotrophic factor, glutamatergic neurotransmission, presynaptic neurotransmitter release, rapid-acting antidepressants
- MeSH terms
- Animals, Antidepressive Agents, Brain, Disease Models, Animal, Humans, Ketamine, Synaptic Transmission, Neuronal Plasticity, Synapses, Synaptic Vesicles, Signal Transduction, Receptors, N-Methyl-D-Aspartate, Neurotransmitter Agents, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.